FDA Inspection 1068791 — Basiem LLC
The FDA completed an inspection of Basiem LLC on Sep 19, 2018 in Madisonville, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 19, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Madisonville, LA (United States)